These results strongly imply that PTEN/PI3K/AKT/mTOR signaling pathways mediates the effects of MTE on Jurkat cells, and provide a novel tool for treatment T-ALL, enhancement PTEN levels. Here, MTOR is linked to acute lymphoblastic leukemia.